Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
About
The purpose of this notice of funding opportunity (NOFO) is to provide investigators with a mechanism to request services from the state-of-the-art Biological Testing Facility that would advance their contraceptive development or reproductive health programs. This NOFO aims to position innovative and validated methods for future regulatory submission and/or clinical development. Applicants do not need to have current NIH funding to apply, but priority may be given to programs receiving NIH support at the time of application submission.
The Biological Testing Facility for Contraception & Reproductive Health grant program provides investigators with access to state-of-the-art biological testing services to advance contraceptive development and reproductive health research initiatives. This funding opportunity is designed for researchers seeking to validate innovative testing methods and position their programs for future regulatory submission or clinical development. Notably, applicants do not require existing NIH funding to apply, making this an accessible opportunity for emerging researchers and established investigators alike. However, programs with current NIH support may receive priority consideration during the review process. This mechanism is ideal for scientists and research teams working on contraceptive innovations, reproductive health solutions, and related biomedical advances who need specialized testing services to strengthen their research portfolios. The program explicitly excludes X01 Clinical Trial mechanisms, focusing instead on foundational biological testing and validation work. Whether you're developing novel contraceptive methods, exploring reproductive health interventions, or refining testing protocols, this facility offers the technical infrastructure and expertise needed to advance your research toward regulatory pathways and clinical implementation.
Funding Facts
● Applications openDeadline
May 7, 2029
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies—service-based access model
Deadline
2029-05-07
Grant Type
federal
Application Cycle
Annual cycle (Next deadline: May 7, 2029)
Best For
Researchers developing contraceptive innovations and reproductive health solutions seeking specialized biological testing and validation services
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Frequently Asked Questions
Who is eligible for Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)?
Eligible applicants include investigators and research organizations developing contraceptive or reproductive health programs. Foreign organizations are eligible to apply; however, non-domestic components of U.S. organizations and foreign components (as defined in the NIH Grants Policy Statement) are not eligible. Applicants do not need current NIH funding, though programs with existing NIH support may receive priority consideration. For complete eligibility requirements, refer to Section III. Eligibility Information in the Notice of Funding Opportunity (NOFO) or contact the program office directly.
How much funding does Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) provide?
Specific funding amounts are not listed for this program cycle. Funding typically supports access to biological testing facility services rather than direct grant awards. Contact the program office or review the official NOFO for details on service availability, cost structures, and any associated funding mechanisms for your specific research needs.
How do I apply for Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)?
Applications are submitted through the standard NIH grants application process. Applicants should review the complete Notice of Funding Opportunity (NOFO) for specific submission instructions, required documentation, and application deadlines. Visit the official NIH Grants & Funding website or the program's dedicated page to access the NOFO, submission portal, and technical assistance resources. The next application deadline is May 7, 2029.
What can Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) funding be used for?
This program provides access to specialized biological testing services to support contraceptive development and reproductive health research. Funds support validated testing methods and innovative approaches designed to advance regulatory submission readiness and clinical development. The program specifically excludes X01 Clinical Trial mechanisms, focusing on foundational biological testing, method validation, and protocol development rather than human clinical trials.
Last updated: July 5, 2026